Unlike Rosiglitazone, Pioglitazone May Lower MI, Stroke Risk

Pioglitazone appears to lower the risk of death, myocardial infarction, and stroke in diabetes patients, just the opposite of the closely related drug rosiglitazone, according to separate metaanalyses on the two agents.